Search Results

treatment of vaginal stenosis resulting from pelvic radiation therapy . Community Oncology 2006 ; 3 : 665 – 671 . 80 Lindsey I George B Kettlewell M Mortensen N . Randomized, double-blind, placebo-controlled trial of sildenafil (Viagra) for

clinicians and on the judgement of experts, in particular. To some extent, the clinical community brought this situation on itself with the variations in care and unnecessary procedure rates that were documented in the late 1980s. Now, unfortunately, the

: Flatiron Health electronic health record data, largely from community oncology practices, from January 2011–April 2018 were used for this retrospective observational study. Treatment-naïve (TN) and relapsed/refractory (RR) second-line patients diagnosed

designed to streamline cancer diagnosis and treatment. Head and neck cancer (HNC) remains a difficult disease to diagnose and treat. Delivery of multimodality treatment for advanced HNC is challenging at both academic centers and in the community setting

individuals with a confirmed cancer diagnosis. Cross-sectional studies may be more relevant to the assessment of adherence to different cancer screening programs. 7 The Canadian Community Health Survey (CCHS) is a cross-sectional study conducted annually and

) coping with cancer through spirituality and community involvement. 1. The predominant sense of loss associated with breast cancer is a consistent theme for all women, across any latitude or longitude. This loss is both physical and emotional. Women

, pulmonology, hematology/oncology, and gynecology within an academic medical center (Vanderbilt University Medical Center [VUMC]) and its affiliated Veterans Health Administration (VHA), including hospital-based and community-based practices. VUMC has an

variable prevalence of different behaviors in different sectors of society. 1 , 9 – 13 The Canadian Community Health Survey (CCHS) is a national survey that has been conducted regularly on an annual basis. 14 It provides population

oncology with interests including lung cancer, esophageal cancer, and thoracic surgery. Dr. D'Amico remains active in the research community with a focus on the molecular biology of lung cancer and esophageal cancer and the genomic analysis of mutations. He

be greatly expanded through integrating resources in the local community, such as Cancer Support Community sites, and nationally (eg, American Cancer Society, CancerCare, LIVESTRONG). Academic and high-volume cancer centers may have greater access